Published in Ann Intern Med on August 15, 1989
AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax (1992) 1.72
Immune activation and collateral damage in AIDS pathogenesis. Front Immunol (2013) 1.08
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One (2012) 1.06
Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res (2010) 0.99
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. J Clin Invest (1991) 0.92
Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines. Antimicrob Agents Chemother (1996) 0.87
Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition. Antimicrob Agents Chemother (1992) 0.85
Status of immune-based therapies in HIV infection and AIDS. Clin Exp Immunol (1992) 0.82
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J Clin Invest (1994) 0.78
Interferons and HIV Infection: The Good, the Bad, and the Ugly. Pathog Immun (2016) 0.77
Continued zidovudine and interferon-alpha therapy in Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1990) 0.75
Packed cell volume Platelet count, PT, PTTK and Fibrinogen concentration of HIV positive patients on antiretroviral drugs. Pak J Med Sci (2016) 0.75
The TIGR Gene Indices: analysis of gene transcript sequences in highly sampled eukaryotic species. Nucleic Acids Res (2001) 8.44
Interferons and their actions. Annu Rev Biochem (1987) 8.36
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes (1999) 7.14
Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol (1999) 5.86
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med (1999) 4.81
Assigning genomic sequences to CATH. Nucleic Acids Res (2000) 4.22
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Visceral abdominal-fat accumulation associated with use of indinavir. Lancet (1998) 4.05
Appropriateness of the decision to transfer nursing facility residents to the hospital. J Am Geriatr Soc (2000) 3.99
Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
A potential role for interleukin-7 in T-cell homeostasis. Blood (2001) 3.56
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med (1997) 3.40
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 3.13
Specificity in deoxyribonucleic acid uptake by transformable Haemophilus influenzae. J Bacteriol (1974) 3.12
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med (2001) 3.05
Indinavir concentrations and St John's wort. Lancet (2000) 3.04
Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol (1985) 3.02
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene (2009) 2.86
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med (1996) 2.86
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med (1991) 2.75
H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest (1977) 2.71
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med (1988) 2.68
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia. Intern Med J (2013) 2.53
Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol (2001) 2.52
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51
Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology Blood Transfusion Task Force. Autologous Transfusion Working Party. Br J Anaesth (1997) 2.49
Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med (1997) 2.49
Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol (1992) 2.45
Constitution of the cell envelope of Haemophilus influenzae in relation to competence for genetic transformation. J Bacteriol (1975) 2.42
Unexplained febrile illnesses after exposure to ticks. Infection with an Ehrlichia? JAMA (1987) 2.37
ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med (1999) 2.23
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Total neuropathy score: validation and reliability study. Neurology (1999) 2.15
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood (2000) 2.15
Influences of flexor sheath continuity and early motion on tendon healing in dogs. J Hand Surg Am (1990) 2.14
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. Br J Pharmacol (2007) 2.13
HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet (1999) 2.13
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med (1993) 2.11
Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem (1994) 2.09
The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience (1987) 2.05
The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol (2000) 2.05
Men account for a scant 3% of all nurses. J Nurse Midwifery (1992) 2.05
Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol (1998) 2.04
Comparison of nucleic acid content in populations of free-living and symbiotic Rhizobium meliloti by flow microfluorometry. J Bacteriol (1977) 2.02
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol (2001) 1.97
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.96
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis (2000) 1.96
Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology (1999) 1.96
Rethinking sedation and agitation management in critical illness. Crit Care Resusc (2003) 1.94
Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med (1988) 1.91
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res (2000) 1.87
Genetic analysis of female gametophyte development and function. Plant Cell (1998) 1.85
Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry (2007) 1.78
Interactions between antibiotics and human neutrophils in the killing of staphylococci. J Clin Invest (1981) 1.74
Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem (1993) 1.71
Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood (1983) 1.71
Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci U S A (1992) 1.71
Amino terminal sequence of the major component of human lymphoblastoid interferon. Science (1980) 1.66
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Ann Intern Med (1990) 1.65
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat (1999) 1.65
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc Natl Acad Sci U S A (2001) 1.65
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Acute caecal volvulus. Br J Surg (1980) 1.63
True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys (2000) 1.62
A rapid classification protocol for the CATH Domain Database to support structural genomics. Nucleic Acids Res (2001) 1.61
Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. Aliment Pharmacol Ther (2007) 1.61
The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis. Neurology (1998) 1.58
Magnesium sulphate attenuates arterial pressure increase during laparoscopic cholecystectomy. Br J Anaesth (2009) 1.58
Primary mouse keratinocyte cultures contain hair follicle progenitor cells with multiple differentiation potential. J Invest Dermatol (1997) 1.58
Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med (1981) 1.58
Anti-D immunoglobulin in RhD prophylaxis. Br J Obstet Gynaecol (1998) 1.56
The Immunology Case Registry. J Clin Epidemiol (2001) 1.56
Lung injury induced by leukocytic proteases. Am J Pathol (1979) 1.56
An outbreak of ehrlichiosis in members of an Army Reserve unit exposed to ticks. J Infect Dis (1989) 1.55
Invasive cribriform carcinoma of the breast. Histopathology (1983) 1.53
Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol (1996) 1.53
Reversible parkinsonism and MRI diffusion abnormalities in cortical venous thrombosis. Neurology (2001) 1.53
Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Neuroepidemiology (2009) 1.53
Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res (1999) 1.52
Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem (1996) 1.51
Determination of burn depth with noncontact ultrasonography. J Burn Care Rehabil (2000) 1.51
Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol (1995) 1.50
Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet (1991) 1.50